Rottlerin: A multifaced regulator of keratinocyte cell cycle

Experimental Dermatology

Volumn 18, Issue 6, 2009, Pages 516-521

  Valacchi, Giuseppe ^a,b   Pecorelli, Alessandra ^a   Mencarelli, Marzia ^a   Carbotti, Paola ^a   Fortino, Vittoria ^a   Muscettola, Michela ^a   Maioli, Emanuela ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Kyung Hee University   (South Korea)

Author keywords

Cyclin D1; Nuclear factor kappa B; p21; Rottlerin

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C DELTA; PROTEIN P21; ROTTLERIN; THYMIDINE;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; EPITHELIZATION; KERATINOCYTE; NONHUMAN; PROTEIN DEPLETION; SKIN INJURY;

ACETOPHENONES; ACTIVE TRANSPORT, CELL NUCLEUS; BENZOPYRANS; CELL CYCLE; CELL LINE, TRANSFORMED; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GENES, BCL-1; GROWTH INHIBITORS; HUMANS; KERATINOCYTES; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; WOUND HEALING;

EID: 66149145893     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00816.x     Document Type: Article

References (31)

1. Gschwendt M, Müller H J, Kielbassa K et al. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 1994: 199: 93-98.
2. Davies S P, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000: 351: 95-105.
3. Soltoff S P. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J Biol Chem 2001: 276: 37986-37992.
4. Soltoff S P. Rottlerin: An inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 2007: 28: 453-458.
5. Torricelli C, Fortino V, Capurro E et al. Rottlerin inhibits the nuclear factor kappaB/Cyclin-D1 cascade in MCF-7 breast cancer cells. Life Sci 2008: 82: 638-643.
6. Krueger J G, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis 2005: 64 (Suppl. 2): 230-236.
7. Schlaak J F, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the TH1 subset. J Invest Dermatol 1994: 102: 145-149.
8. Detmar M, Brown L F, Claffey K P et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994: 180: 1141-1146.
9. Creamer D, Allen M, Jaggar R et al. Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor. Arch Dermatol 2002: 138: 791-796.
10. Sabat R, Philipp S, Höflich C et al. Immunopathogenesis of psoriasis. Exp Dermatol 2007: 16: 779-798.
11. Berger E M, Gottlieb A B. Developments in systemic immunomodulatory therapy for psoriasis. Curr Opin Pharmacol 2007: 7: 434-444.
12. Banno T, Gazel A, Blumenberg M. Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes. J Biol Chem 2005: 280: 18973-18980.
13. Doger F K, Dikicioglu E, Ergin F et al. Nature of cell kinetics in psoriatic epidermis. J Cutan Pathol 2007: 34: 257-263.
14. Lizzul P F, Aphale A, Malaviya R et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept. J Invest Dermatol 2005: 124: 1275-1283.
15. Schoop V M, Mirancea N, Fusenig N E. Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol 1999: 112: 343-353.
16. Lehman T A, Modali R, Boukamp P et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 1993: 14: 833-839.
17. Susarla B T, Robinson M B. Rottlerin, an inhibitor of protein kinase Cdelta (PKCdelta), inhibits astrocytic glutamate transport activity and reduces GLAST immunoreactivity by a mechanism that appears to be PKCdelta-independent. J Neurochem 2003: 3: 635-645.
18. Welters H J, Smith S A, Tadayyon M, Scarpello J H, Morgan N G. Evidence that protein kinase C delta is not required for palmitate-induced cytotoxicity in BRIN-BD11 beta-cells. J Mol Endocrinol 2004: 32: 227-235.
19. Li X, Stark G R. NFκB -dependent signaling pathways. Exp Hematol 2002: 30: 285-296.
20. Breitkreutz D, Braiman-Wiksman L, Daum N, Denning M F, Tennenbaum T. Protein kinase C family: On the crossroads of cell signaling in skin and tumor epithelium. J Cancer Res Clin Oncol 2007: 133: 793-808.
21. Dietrich C, Gumpert N, Heit I et al. Rottlerin induces a transformed phenotype in human keratinocytes. Biochem Biophys Res Commun 2001: 282: 575-579.
22. Heit I, Wieser R J, Herget T et al. Involvement of protein kinase Cdelta in contact-dependent inhibition of growth in human and murine fibroblasts. Oncogene 2001: 20: 5143-5154.
23. Min C, Eddy S F, Sherr D H, Sonenshein G E. NF-kappaB and epithelial to mesenchymal transition of cancer. Cell Biochem 2008: 104: 733-744.
24. Vidal A, Koff A. Cell-cycle inhibitors: Three families united by a common cause. Gene 2000: 247: 1-15.
25. Luo Y, Hurwitz J, Massagué J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 1995: 375: 159-161.
26. Brown K A, Roberts R L, Arteaga C L, Law B K. Transforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein. Breast Cancer Res 2004: 6: R130-R139.
27. el-Deiry W S, Tokino T, Velculescu V E et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993: 75: 817-825.
28. Das D, Pintucci G, Stern A. MAPK-dependent expression of p21(WAF) and p27(kip1) in PMA-induced differentiation of HL60 cells. FEBS Lett 2000: 472: 50-52.
29. Cozzi S J, Parsons P G, Ogbourne S M et al. Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway. Cancer Res 2006: 66: 10083-10091.
30. Maioli E, Torricelli C, Fortino V. Functional interactions of protein kinase A and C in signalling networks: A recapitulation. Cell Mol Life Sci 2006: 63: 637-641.
31. Ferrandi C, Ardissone V, Ferro P et al. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther 2007: 322: 923-930.